Extracellular Vesicles for Rejection Monitoring in Cardiac Transplantation

Recruiting Observational Study
Rejection Heart Transplant
No Placebo Group Every participant receives an active treatment — no one gets a placebo. No Study Drug Researchers observe your health over time — no experimental treatment is given.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
18 and older
Sex
Any
Study type
Observational
Participants needed
30 (estimated)
Sponsor
Laurenz Kopp Fernandes · Other
Think this trial could be right for you?

Answer a few quick questions to see if you may meet the eligibility requirements.

Check Your Eligibility
About This Trial
This study will analyze extracellular vesicle (EV)-derived protein profiles in heart transplantated patients during the first 15 months post-transplantation to investigate, if there are distinct EV-derived proteins or protein patterns that allow early and reliable diagnosis of acute cardiac allograft rejection. Additionally, it will explore temporal changes in the EV-derived protein profile during…
Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion Criteria: * Subject is either on the heart transplant waiting list or is still hospitalised following HTx surgery. * Age of subject is ≥ 18 years. * Subject is female or male. * Capacity to consent. * Signed written informed consent. * For female subjects: 1. Confirmed post-menopausal …
Contacts

Laurenz Kopp Fernandes

+49 (0)30 4593 2154

laurenz.koppfernandes@dhzc-charite.de

CONTACT